baber/WOPTO huggingface dataset:
Patent MX-2021002611-A (MX)
Title: Pharmaceutical composition comprising cyclodextrin compexes of anethole trithione or derivatives thereof.
Inventor: PINEAU NICOLAS
IPC: A61K47/69
Filed: 2019-09-06
Abstract: The present invention relates to a composition comprising anethole trithione or a derivative thereof of formula (I), sulfobutyl ether-beta-cyclodextrin and optionally a co-solvent, wherein the ratio of the sulfobutyl ether-beta-cyclodextrin to the compound of formula (I) ranges from 10 to 400, preferably from 57 to 200. The invention further relates to the composition described in the present application for use as a drug, namely for the treatment and/or the prevention of free oxygen radical-related diseases. The invention is also directed to a kit-of-parts and/or a medical device comprising said composition. Lastly, the present invention is directed to a method for solubilizing a compound of formula (I) in an aqueous medium..
Patent MX-2021002839-A (MX)
Title: Fire hose and material therefore.
Inventor: RYDER NOAH L
IPC: F16L11/08
Filed: 2019-09-20
Abstract: Described herein are fire hoses incorporating new combinations of materials to increase the hose's resilience. Resilient hoses include those made with silicone-coated fabrics or with thermally-resistant fabrics or both.
Patent MX-2021003822-A (MX)
Title: Phosphoric acid production methods and compositions.
Inventor: ZHANG LEI
IPC: C01B25/18
Filed: 2019-10-02
Abstract: A wet process phosphoric acid production method comprises digesting phosphate- containing ore in a slurry comprising sulfuric acid, whereby phosphoric acid and calcium sulfate crystals are formed; and separating the phosphoric acid from the calcium sulfate crystals; wherein a defoamer and a poly(carboxylic acid), or salt thereof, having a weight- average molecular weight of less than 1,000,000 grams per mole (g/mol), are added to the slurry. The poly (carboxylic acid) can be a poly(acrylic acid), or salt thereof, and the defoamer can be a dialkyl sulfo succinate salt and an aliphatic alcohol or a fatty acid ester. The method enhances separation of phosphoric acid from calcium sulfate crystals in wet process phosphoric acid production by any one of increasing the volume average particle size of the calcium sulfate crystals, increasing filtration rate, and reducing foam formation.
Patent MX-2021005119-A (MX)
Title: Aerosolised formulation.
Inventor: CABOT ROSS
IPC: A24B15/167
Filed: 2019-10-31
Abstract: There is provided an aerosolised formulation comprising (i) water in an amount of at least 50 wt.% based on the aerosolised formulation; and (ii) at least one active agent; wherein the aerosol has the following particle size distribution: D50 of from 2 to 6Âµm.
Patent MX-2021005869-A (MX)
Title: Dihydroindolizinone derivative.
Inventor: KONDO TAKASHI
IPC: A61P7/02
Filed: 2017-06-08
Abstract: A compound represented by general formula (I) (wherein all symbols are as defined in the description) or a salt, solvate, N-oxide form or prodrug thereof is a potent FXIa inhibitor, has excellent oral absorption properties and kinetics in blood, can exert a potent anti-coagulation activity over a long period of time after being administered orally, and has a discrepancy between the anti-coagulation activity thereof and the CYP-inhibiting activity thereof. Therefore, the compound or the salt, solvate, N-oxide form or prodrug thereof can be used as an efficient prophylactic and/or therapeutic agent for vascular occlusive diseases.
Patent MX-2021007323-A (MX)
Title: Apparatus and method for source separation using an estimation and control of sound quality.
Inventor: HERRE JÜRGEN
IPC: G10L25/60
Filed: 2019-12-20
Abstract: An apparatus for generating a separated audio signal from an audio input signal is provided. The audio input signal comprises a target audio signal portion and a residual audio signal portion. The residual audio signal portion indicates a residual between the audio input signal and the target audio signal portion. The apparatus comprises a source separator (110), a determining module (120) and a signal processor (130). The source separator (110) is configured to determine an estimated target signal which depends on the audio input signal, the estimated target signal being an estimate of a signal that only comprises the target audio signal portion. The determining module (120) is configured to determine one or more result values depending on an estimated sound quality of the estimated target signal to obtain one or more parameter values, wherein the one or more parameter values are the one or more result values or depend on the one or more result values. The signal processor (130) is configured to generate the separated audio signal depending on the one or more parameter values and depending on at least one of the estimated target signal and the audio input signal and an estimated residual signal, the estimated residual signal being an estimate of a signal that only comprises the residual audio signal portion.
Patent MX-2021007665-A (MX)
Title: Novel methods.
Inventor: MATES SHARON
IPC: C07D241/36
Filed: 2014-12-03
Abstract: The disclosure provides the use of particular substituted heterocycle fused gamma-carboline compounds as pharmaceuticals for the treatment of residual symptoms of psychosis or schizophrenia. The disclosure also provides novel long acting injectable formulations of particular substituted heterocycle fused gamma-carboline compounds and use of such long acting injectable formulations for the treatment of residual symptoms of psychosis or schizophrenia.
Patent MX-2021009206-A (MX)
Title: Deoxy- cytidine or uridine derivatives for use in cancer therapies.
Inventor: ROBERTSON ADAM BRIAN
IPC: A61K31/7072
Filed: 2020-02-03
Abstract: The present invention relates to a compound of Formula (I), or a stereoisomer, solvate, tautomer or pharmaceutically acceptable salt thereof, wherein X, W<sub>1</sub>, W<sub>2</sub>, Y, Z, R<sub>1</sub>, R<sub>2 </sub>and R<sub>3</sub> are as defined in the disclosure herein, for use in therapy, particularly for use in the treatment of cancer. The present invention also relates to methods of treating cancer comprising the administration of a compound of Formula (I) to a subject in need thereof, and to pharmaceutical compositions and kits comprising such compounds.
Patent MX-2021009507-A (MX)
Title: Chimeric antigen receptor-modified cells for the treatment of cldn6-expressing cancers.
Inventor: SAHIN UGUR
IPC: C07K16/28
Filed: 2020-02-05
Abstract: The present disclosure relates to a chimeric antigen receptor (CAR) showing highly specific and sensitive recognition of CLDN6 expressing target cells as well as a high potential for survival and repetitive stimulation of CAR T cells.
Patent MX-2021010811-A (MX)
Title: Semiflexible prefabricated monolithic panels.
Inventor: MEDINA RUIZ JUAN MANUEL
IPC: E04B2/00
Filed: 2021-08-25
Abstract: The present invention relates to a semiflexible prefabricated panel system to form formwork. It offers several advantages in casting structural elements made from heat-treated, virgin, or plastic materials for recycling them, thus generating a novel niche for reusing waste plastics. Said materials and systems allow controlling and customizing sections, weight, shapes, and mechanical properties. Also, they are economical formworks, very light in weight, and highly resistant, joined by a simple braid of annealed wire, using only wire to unscramble them by cutting, thus providing excellent help to construction since it reduces the time invested in assembling and dismantling the forms by up to 80%.
Patent MX-2021011072-A (MX)
Title: Method for controlling a production process for producing components.
Inventor: OBERPARLEITER PETER
IPC: G05B19/418
Filed: 2020-03-13
Abstract: Method for controlling a production process for producing components, wherein the components or a manufacturing device used to produce the components has/have at least one first feature which can be captured using metrology; at least having the following steps: a) determining a test plan for capturing the first feature with a first value of a first test frequency, wherein at least one first stability criterion is defined for the first feature; b) producing the components and carrying out the test plan in a parallel manner, wherein the first feature is tested at the first test frequency; c) evaluating the test results; d) changing the first test frequency, wherein the first test frequency is increased if at least one test result for the first feature violates the first stability criterion; wherein the first test frequency is reduced if all test results are in accordance with the first stability criterion.
Patent MX-2021011152-A (MX)
Title: Ammonia oxidizing bacteria for treatment of acne.
Inventor: WEISS LARRY
IPC: A61P31/04
Filed: 2018-01-08
Abstract: A method for treating a skin disorder, e.g., acne, e.g. acne vulgaris, in a subject is provided. The method comprises administering, e.g., applying, e.g., topically administering, ammonia oxidizing bacteria, e.g., a preparation comprising ammonia oxidizing bacteria, to a surface of the subject. Preparations comprising ammonia oxidizing bacteria for treating such skin disorder, e.g., acne, e.g. acne vulgaris in a subject are also provided.
Patent MX-2021012471-A (MX)
Title: Cd40 specific dna aptamers as vaccine adjuvants.
Inventor: HARGIS BILLY
IPC: A61K31/713
Filed: 2020-04-13
Abstract: The present invention provides immunostimulatory nucleic acids that have an affinity to a specific target protein. The present invention also provides templates and methods for making and using the immunostimulatory nucleic acids. Further, methods for linking the immunostimulatory nucleic acids to antigens and using the resulting complexes to enhance an immune response are provided.
Patent MX-2022000273-A (MX)
Title: Avoiding false detection associated with wake-up signal.
Inventor: WILHELMSSON LEIF
IPC: H04W52/02
Filed: 2020-06-02
Abstract: A method for a wireless transmitter is disclosed. The method comprises transmitting a wake-up signal over a frequency range during a time interval by transmitting a first signal part over a first frequency interval within the frequency range during the time interval and transmitting a second signal part over a second frequency interval within the frequency range during the time interval. The first and second frequency intervals are non-overlapping. The first signal part has a first auto-correlation value, and the second signal part is specifically constructed to provide a second autocorrelation value of the signal comprising the first and second signal parts which is lower than the first auto-correlation value. The invention to solve the problem of false detection of an MC-OOK modulated wake-up signal in an IEEE 802.11 system using OFDM.
Patent MX-2022001058-A (MX)
Title: Anti-hk2 chimeric antigen receptor (car).
Inventor: SINGH SANJAYA
IPC: C07K16/30
Filed: 2020-07-23
Abstract: The present disclosure provides for chimeric antigen receptors (CARs) that specifically target a human Kallikrein-2 (hK2), and immunoresponsive cells comprising such CARs, for the treatment of cancer.
Patent MX-2022001264-A (MX)
Title: Urea compound for antagonizing lpa1 receptor.
Inventor: KURODA SHOICHI
IPC: A61P43/00
Filed: 2020-07-29
Abstract: The present invention provides a compound represented by formula (I) or a pharmaceutically acceptable salt thereof which has the effect of antagonizing the LPA1 receptor.
Patent MX-2022001680-A (MX)
Title: Fusion proteins against sialosylated glycosphingolipids and sialated glycoproteins and uses thereof.
Inventor: FERNANDES FRANCIS V A
IPC: A61K39/00
Filed: 2020-08-07
Abstract: The present invention relates to the fusion proteins against a glycocalyx, found to be associated with several human post-translational modified proteins linked to cancer cell lines. The fusion proteins of the present invention are able to bind only to sialylated glycosphingolipids and sialylated glycoproteins and well as their independent constituents the monosaccharide sugars such as neu5ac, galnac and gal that constitute the glycocalyx. The products claimed can be used for diagnosis and treatment of various cancers. Apoptosis via Caspase 3 occurs in cancer cells when the fusion protein bound to targets is sequestered in lysosomes. The fusion protein is not seen in any other organelle of the cell except for lysosomes.
Patent MX-2022003718-A (MX)
Title: Antibodies that bind cd39 and uses thereof.
Inventor: PRINZ BIANKA
IPC: C07K16/28
Filed: 2020-09-14
Abstract: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.
Patent MX-2022004070-A (MX)
Title: Optimizing bra sizing according to the 3d shape of breasts.
Inventor: PEI JIE
IPC: A41C3/00
Filed: 2020-10-03
Abstract: Methods and systems for developing a sizing system through categorization and selection of prototypes, which can be regarded as the most appropriate fit model, is described. Once categorized and prototypes are selected, recommendations for the sizing of a target body part may be issued.
Patent MX-2022004860-A (MX)
Title: Improvements in, or relating to, sliding spool valves, and methods therefor.
Inventor: DUFF WILLIAM MICHAEL
IPC: F16K11/07
Filed: 2019-10-30
Abstract: Disclosed is a spool valve to valve a fluid between at least one inlet port and at least one outlet port, having a bore with a spool operably associated therein. The bore has one or more inlet ports and at least one outlet port. Located in the bore is at least one in-bore seal, the seal fluidly sealing on a seal outer diameter to an inside diameter of the bore, and selectively fluidly sealing on a seal inside diameter to a spool outside diameter. Present also is at least one spacer located in the bore, adjacent the at least one in-bore seal having a fluid communication from a spacer internal diameter to a spacer external diameter with at least one inlet port, or the at least one outlet port. The spool moves to allow or prevent flow from an inlet port to outlet port.
Patent MX-2022005452-A (MX)
Title: Antibody-drug conjugates targeting claudin 18.2.
Inventor: LI RUNSHENG
IPC: A61K47/68
Filed: 2020-11-05
Abstract: Provided are antibody-drug conjugates containing a drug moiety attached to a n antibody or fragment thereof having binding specificity to the wild-type human claudin 18.2 (CLDN18.2) protein. The antibody or the fragment thereof binds to the Î²3-Î²4 loop (residues 45-63 of SEQ ID NO: 30, NYQGLWRSCVRESSGFTEC) and the Î²5 strand (residues 169-172 of SEQ ID NO: 30, YTFG) of CLDN18.2.
Patent MX-2022006251-A (MX)
Title: Novel insulin analogues and uses thereof.
Inventor: OLSEN HELLE BIRK
IPC: C07K14/62
Filed: 2020-12-10
Abstract: The present invention is in the therapeutic field of drugs for medical conditions relating to diabetes. More specifically the invention relates to insulin analogues of human insulin. The invention provides pharmaceutical compositions comprising such insulin analogues and the uses if the such analogues for the treatment or prevention of medical conditions relating to diabetes.
Patent MX-2022007050-A (MX)
Title: Injection and infusion site treatment devices and methods.
Inventor: LIPMAN KELLEY J
IPC: A61B17/08
Filed: 2020-12-10
Abstract: Devices, kits and methods described herein are be used at chronic injection site or in conjunction with an indwelling catheter or cannula. A book-like packaging, applicator and/or tensioning device with an opening and optional indicia to align the catheter or cannula to the opening may be used to apply a dressing to a subject. The packaging, applicator and/or tensioning device may apply and/or maintain a strain in an elastic dressing.
Patent MX-2022007377-A (MX)
Title: Non-heat treated wire rod having excellent drawability and impact toughness and method for manufacturing same.
Inventor: MUN Dong - Jun
IPC: C22C38/38
Filed: 2020-12-11
Abstract: Provided are a non-heat treated wire rod having excellent drawability and impact toughness and a method for manufacturing same. The non-heat treated wire rod of the present invention contains, in weight%, C: 0.02-0.30%, Si: 0.05-0.8%, Mn: 0.5-2.0%, Cr: 1.0% or less, P: 0.03% or less, S: 0.03% or less, sol.Al: 0.01-0.07%, N: more than 0.01% and no more than 0.02%, and at least one of Nb: 0.1% or less, V: 0.5% or less, Ti: 0.1% or less, and the balance being Fe and inevitable impurities, and has a microstructure of a wire rod containing ferrite and pearlite, wherein the ferrite is formed continuously or discontinuously at predetermined intervals in a direction parallel to the rolling direction of the wire rod to configure a plurality of ferrite layers, and the pearlite is formed continuously or discontinuously in the insides or outsides of the ferrite layers in a direction parallel to the rolling direction of the wire rod to configure a plurality of pearlite layers.
Patent MX-2022010186-A (MX)
Title: Botulinum neurotoxins for use in therapy.
Inventor: ABUSHAKRA SAWSAN
IPC: A61K8/02
Filed: 2019-09-20
Abstract: Disclosed herein are compositions and methods for use in therapeutic procedures. Use of a "fast-acting" botulinum toxin for cosmetic treatment and/or to prevent or reduce scarring. "Fast-acting" refers to a botulinum toxin that produces effects in the patient more rapidly than those produced by, for example, a botulinum neurotoxin type A. The "fast-acting" botulinum toxin, for example, type E.
Patent MX-2022010727-A (MX)
Title: Inter-frame prediction method, coder, decoder, and computer storage medium.
Inventor: YANG NING
IPC: H04N19/503
Filed: 2021-04-23
Abstract: Disclosed are an inter-frame prediction method, a coder, a decoder, and a computer storage medium. The method is applied to the decoder. The method comprises: parsing a code stream, and obtaining a prediction mode parameter of the current block; when the prediction mode parameter indicates the use of a preset inter-frame prediction mode to determine an inter-frame prediction value of the current block, determining at least one initial candidate position of the current block; when the at least one initial candidate position exceeds the boundary of the largest coding unit (LCU) of the current block, adjusting the at least one initial candidate position to obtain at least one target candidate position of the current block; on the basis of the at least one target candidate position, determining at least one time domain motion information of the current block; on the basis of the at least one time domain motion information, constructing a new motion information candidate list; and according to the new motion information candidate list, determining the inter-frame prediction value of the current block.
Patent MX-2022012107-A (MX)
Title: Functional wafers by 3d printing.
Inventor: CHIU HAO WEN
IPC: B29D11/00
Filed: 2021-03-31
Abstract: A method of manufacturing an optical lens (417, 901), comprising: obtaining (S301) a transparent thermoplastic (TP) carrier (410, 1210) with at least one smooth surface; printing (S305), via a 3-D printer on the side opposite to the at least one smooth surface of the transparent TP carrier (410, 1210), at least one transparent layer (420, 1220) using a thermoplastic filament (403), each transparent layer (420, 1220) having a predetermined light filtering property, thereby forming a functional layer (420, 1220); and performing (S307) an injection over-molding process (415) to fuse bond the functional layer (420, 1220) to a thermoplastic substrate thereby forming the optical lens, wherein the at least one smooth surface of the transparent TP carrier (410, 1210) forms a smooth surface of the manufactured optical lens (417, 901).
Patent MX-2022014213-A (MX)
Title: Use of tlr4 modulator in the treatment of coccidiosis.
Inventor: DAHL ANDREW A
IPC: A61K39/39
Filed: 2021-05-14
Abstract: An effective treatment mechanism in controlling a variety of diseases by modulating the inflammatory response often associated with disease is disclosed. The disclosed inventive concept is based on the modulation of TLR4 by use of a member of the <i>Variovorax</i> group or the <i>Rhodobacter</i> group. Specifically, the Gram-negative bacterium <i>Variovorax paradoxus</i> or the Gram-negative bacterium <i>Rhodobacter sphaeroides</i> is used according to the disclosed inventive concept in the treatment of disease by reducing or inhibiting inflammatory responses.
Patent MX-JL01000016-A (MX)
Title: Improvements to belt buckle.
Inventor: ROBLES FELIPE MARQUEZ
IPC: A44B11/00
Filed: 2001-06-25
Abstract: This invention is directed to an improved belt buckle whose fabrication is made with a cold-rolled sheet, cut and die cast in a double-matrix die (with two opeations); the first die cast (first operation), will make three slits in said sheet; two of them "U"-shaped and at the opposite end, and another straight with an oval tip remaining outward, the second die cast (second operation), cuts the cold-rolled sheet in an oval, rectangular, round, square shape and at the same moment it is been cut, it is shell-shaped. Subsequently, it is passed to a pneumatic machine of 60 lbs. at least in order to push rearward the two "U"-shaped slits, so that inside the "U" will be two oval bores wherein a rectangular galvanized wire will be placed, previously prepared, inside the oval bores at the "U"- shaped slits, finishing with this the belt buckle.
Patent MX-PA00007574-A (MX)
Title: Method for manufacturing resin-impregnated endless belt structures for papermaking machines and similar industrial applications.
Inventor: DESMOND MCGAHERN
IPC: B29D29/00
Filed: 2000-08-02
Abstract: The present discloses a resin-impregnated endless belt a shoe type long contact line press or calender for other papermaking and paper-processing applications, has an open base fabric in the form of an endless loop with an inner surface, an outer surface, a machine direction and a cross-machine direction. A coating of a first polymeric resin is on the inner surface of the base fabric. The polymeric resin impregnates and renders the base fabric impermeable to liquids, and forms a layer on the inner surface thereof. The coating is smooth and provides the belt with a uniform thickness. The band is manufactured mounting the fabric around a first roller and a second roller, which are separated for placing the base fabric under tension in the machine direction. A conveyor band is placed within the base fabric at a pre-selected distance from the inner surface thereof. The conveyor band and the base fabric run at a common speed, and initiating at the lateral edge of the base fabric, it is dis tributed polymeric resin over the base fabric over the conveyor band from a distributor. The conveyor band as well as the distributor move crosswise through the base fabric when the latter is coated in a spiral way.
Patent MX-PA00007716-A (MX)
Title: Process for preparing 4,6-dichloro-5-fluoropyrimidine.
Inventor: HOLGER WEINTRITT
IPC: A01N43/54
Filed: 2000-08-07
Abstract: The invention relates to a novel process for preparing 4,6-dichloro-5-fluoropyrimidine.
Patent MX-PA01003608-A (MX)
Title: Method for burning carbonate-containing material.
Inventor: WALTER EGGER
IPC: F27B1/04
Filed: 2001-04-09
Abstract: In a method for burning carbonate-containing material the latter moves as a result of gravity in counter-current to the cooling and combustion air through a shaft kiln. The fuel supply takes place by means of burning lances introduced into the granular burning material at right angles to the shaft wall. On limiting the grain size and the residence time as a result of this type of fuel supply it is possible to achieve high burning temperatures even suitable for hard burning without there being any sintering together of the granular burning material.